Jon L. Giacomin, CEO, Pharmaceutical Segment at CARDINAL HEALTH INC (CAH), sold 46,540 shares at $72.87 ($3.4M) on 2017-05-12, disclosed to the SEC on 2017-05-15.
Open-market sale of $3.4M CAH by CEO, Pharmaceutical Segment. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.87 | 23,270 | $1.7M | 50.0% |
| 2 | $72.87 | 23,270 | $1.7M | 50.0% |
| Total | $72.87 avg | 46,540 | $3.4M | 100% |
| Filing → |
| CAH | SELL | 2016-08-17 | $3.9M | — | Filing → |